• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体内自动心脏复律除颤器在心脏性猝死幸存者中的临床评估。

Clinical evaluation of the internal automatic cardioverter-defibrillator in survivors of sudden cardiac death.

作者信息

Reid P R, Mirowski M, Mower M M, Platia E V, Griffith L S, Watkins L, Bach S M, Imran M, Thomas A

出版信息

Am J Cardiol. 1983 Jun;51(10):1608-13. doi: 10.1016/0002-9149(83)90195-9.

DOI:10.1016/0002-9149(83)90195-9
PMID:6858865
Abstract

An R-wave synchronous implantable automatic cardioverter-defibrillator (IACD) was evaluated in 12 patients with repeated episodes of cardiac arrest who remained refractory to medical and surgical therapy. Seven men and 5 women, average age 61 years, surgically received a complete IACD system. Coronary artery disease was found in 11 and the prolonged Q-T syndrome in 1. The average ejection fraction was 34%, and 6 patients had severe congestive heart failure (New York Heart Association class III or IV). The IACD is a completely implantable unit consisting of 2 bipolar lead systems. One system uses a lead in the superior vena cava and on the left ventricular apex through which the cardioverting pulse is delivered. The second system employs a close bipolar lead implanted in the ventricle for sensing rate. After the onset of ventricular tachycardia or fibrillation, the IACD automatically delivers approximately 25 J. Postoperative electrophysiologic study in 10 and spontaneous ventricular tachycardia in 1 patient demonstrated appropriate IACD function and successful conversion in all with an average of 18 +/- 4 seconds. The induced arrhythmias were ventricular tachycardia (160 to 300 beats/min) in 9 and ventricular fibrillation in 1. These data demonstrate that ventricular tachycardia, not ventricular fibrillation, was the predominant rhythm induced during programmed ventricular stimulation in these survivors of cardiac arrest and that the IACD effectively responded to a wide range of ventricular tachycardia rates as well as ventricular fibrillation. Use of the IACD offers an effective means of therapy for some patients who otherwise may not have survived.

摘要

对12例反复发生心脏骤停且对药物和手术治疗均无效的患者进行了R波同步植入式自动心脏复律除颤器(IACD)评估。其中7名男性和5名女性,平均年龄61岁,通过手术植入了完整的IACD系统。11例患者患有冠状动脉疾病,1例患有长QT综合征。平均射血分数为34%,6例患者患有严重充血性心力衰竭(纽约心脏协会III或IV级)。IACD是一个完全可植入的装置,由2个双极导联系统组成。一个系统使用一根位于上腔静脉和左心室心尖的导联,通过该导联输送复律脉冲。第二个系统采用一根植入心室的紧密双极导联来感知心率。在室性心动过速或颤动发作后,IACD自动输送约25焦耳的能量。10例患者术后进行了电生理研究,1例患者出现自发性室性心动过速,结果显示IACD功能正常,所有患者均成功转复,平均转复时间为18±4秒。诱发的心律失常中,9例为室性心动过速(160至300次/分钟),1例为心室颤动。这些数据表明,在这些心脏骤停幸存者的程控心室刺激过程中,诱发的主要节律是室性心动过速而非心室颤动,并且IACD对广泛的室性心动过速心率以及心室颤动均能有效响应。使用IACD为一些原本可能无法存活的患者提供了一种有效的治疗手段。

相似文献

1
Clinical evaluation of the internal automatic cardioverter-defibrillator in survivors of sudden cardiac death.体内自动心脏复律除颤器在心脏性猝死幸存者中的临床评估。
Am J Cardiol. 1983 Jun;51(10):1608-13. doi: 10.1016/0002-9149(83)90195-9.
2
Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias.植入式自动心脏复律除颤器与左心室功能不全及恶性室性心律失常患者的生存率
Ann Intern Med. 1988 Oct 1;109(7):529-34. doi: 10.7326/0003-4819-109-7-529.
3
The automatic implantable cardioverter defibrillator as a therapeutic modality for recurrent ventricular tachycardia: a case study.
Prog Cardiovasc Nurs. 1990 Jan-Mar;5(1):6-12.
4
Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.使用带有三电极系统的植入式心脏复律除颤器进行心内膜除颤的初步临床经验。
Arch Intern Med. 1989 Oct;149(10):2333-9.
5
[The implantable automatic cardioverter-defibrillator].[植入式自动心脏复律除颤器]
Herz. 1990 Apr;15(2):111-25.
6
Effect of electrophysiological testing on ejection fraction during cardioverter/defibrillator implantation.心脏复律/除颤器植入过程中电生理测试对射血分数的影响。
Ann Thorac Surg. 1988 Mar;45(3):315-8. doi: 10.1016/s0003-4975(10)62471-x.
7
Clinical experience in patients with implantable cardioverter defibrillators.植入式心脏复律除颤器患者的临床经验。
Jpn Circ J. 1991 Jul;55(7):669-75. doi: 10.1253/jcj.55.669.
8
The automatic implantable defibrillator. New Modality for treatment of life-threatening ventricular arrhythmias.植入式自动除颤器。治疗危及生命的室性心律失常的新方法。
Pacing Clin Electrophysiol. 1982 May;5(3):384-401. doi: 10.1111/j.1540-8159.1982.tb02246.x.
9
Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.使用可穿戴式除颤器管理心脏结节病中的心脏性猝死。
PLoS One. 2018 Mar 22;13(3):e0194496. doi: 10.1371/journal.pone.0194496. eCollection 2018.
10
Assessment of a prototype implantable cardioverter for ventricular tachycardia. Relation between synchronisation of sensing and origin of the tachycardia.用于室性心动过速的原型植入式心脏复律器的评估。感知同步与心动过速起源之间的关系。
Br Heart J. 1984 Oct;52(4):385-91. doi: 10.1136/hrt.52.4.385.

引用本文的文献

1
Benefits of treatment with implantable cardioverter-defibrillators in patients with stable ventricular tachycardia without cardiac arrest.植入式心脏复律除颤器治疗无心脏骤停的稳定性室性心动过速患者的益处。
Br Heart J. 1995 Feb;73(2):158-63. doi: 10.1136/hrt.73.2.158.
2
Assessment of a prototype implantable cardioverter for ventricular tachycardia. Relation between synchronisation of sensing and origin of the tachycardia.用于室性心动过速的原型植入式心脏复律器的评估。感知同步与心动过速起源之间的关系。
Br Heart J. 1984 Oct;52(4):385-91. doi: 10.1136/hrt.52.4.385.
3
Indications for different modes of surgical therapy in medically refractory ventricular arrhythmias.
药物难治性室性心律失常不同手术治疗方式的适应证。
Ann Surg. 1986 Jun;203(6):679-84. doi: 10.1097/00000658-198606000-00013.
4
A Canadian hospital's experience with the automatic implantable cardioverter/defibrillator.一家加拿大医院使用植入式自动心脏复律除颤器的经验。
CMAJ. 1987 Nov 1;137(9):809-15.